Objective: A polymorphism at position 825(C→T) of the G protein b3 (GNB3 ) gene was found to be associated with enhanced transmembrane signalling as well as with an increased prevalence of arterial hypertension. The aim of the present study was to further investigate the association of the GNB3 C825T allele status with arterial hypertension in a large population-based sample and its association with specific end organ damage, i.e. myocardial infarction (MI). Methods: Individuals from a population-based sample (n52052) and patients suffering from premature MI (age at first MI #60 years, n5606) were studied by questionnaire as well as by physical examination and biochemical analyses. Results: In the population-based sample, the prevalence of arterial hypertension (blood pressure $160 / 95 mmHg and / or antihypertensive medication) was higher in individuals with the TT genotype (41.8%) as compared to heterozygote individuals (36.6%) or those with the CC genotype (32.75%) (P50.02). This association was predominantly found in men. Moreover, men without antihypertensive medication carrying the TT genotype showed higher diastolic blood pressure than those carrying the CC genotype (86.5 vs. 83.7 mmHg, P50.04). However, the genotype distribution and the allele frequencies were similar in both, the population-based and the MI patient sample. Furthermore, neither the age at the time of MI nor the location of the MI were related to the genotype distribution. Similarly, gender and age stratified analyses did not show any association of the GNB3 genotype and MI. Conclusions: In male individuals from a large population-based sample, the T allele of the GNB3 polymorphism was associated with arterial hypertension. However, the effects of the GNB3 825T allele on blood pressure were small and did not translate to a clinically relevant increase of risk for MI.
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structural changes in the b-subunit [2] . Moreover, an triglycerides were below 400 mg / dl (4.52 mmol / l). Data enhanced signal transduction via pertussis toxin-sensitive on 608 of these individuals have been reported previously G proteins was observed in lymphoblast lines from hy- [5] . pertensive individuals carrying the T allele [2] , which suggests that this genetic variation may indeed affect signal transduction. In recent studies, the association of the 2.2. Myocardial infarction patients T allele of the GNB3 polymorphism with arterial hypertension has been confirmed in smaller cohorts [3] [4] [5] . HowPatients suffering from premature myocardial infarction ever, some authors reported divergent results [6, 7] . Based (MI; first MI prior to the age of 60 years) were identified on the originally reported relative risk of arterial hypertenthrough the Augsburg MONICA MI register. Starting in sion of 1.44 for individuals carrying the TT genotype [2] , 1984, this register has collected information on all patients none of the previous studies was sufficiently powered to suffering from MI in the urban and surrounding rural areas conclusively document a positive association with arterial of Augsburg. The diagnosis of MI was established accordhypertension.
ing to the MONICA diagnostic criteria [8] . In June 1996, a The aim of the present study was, therefore, to investitotal of 1187 patients being alive and having suffered from gate the association of the GNB3 C825T allele status with premature MI were registered. Between 1996 and 1997, all arterial hypertension in a large, sufficiently powered individuals with living siblings were contacted and, with population-based sample (n52052). Since arterial hyperinformed consent, invited to participate in the study. A tension is an important risk factor for development of total of 606 MI patients (529 male, 77 female) were cardiovascular complications, such as myocardial infarcstudied according to a similar protocol as described above. tion, a genetic variation causing arterial hypertension may
The investigation conforms with the principles outlined in also be an important candidate gene for myocardial the Declaration of Helsinki [10] . infarction. Thus, the second aim of this work was to examine the association of the GNB3 C825T polymorphism with myocardial infarction in 606 affected patients.
Arterial hypertension
For this study, arterial hypertension was defined for MI patients and normal population as blood pressure $160 / 95 2. Methods mmHg or regular intake of antihypertensive medication. Antihypertensive medication was defined as the intake of 2.1. Population-based sample drugs known to lower blood pressure, such as diuretics, b-blockers, vasodilators, ACE inhibitors, a-blockers, cal-A large population-based sample (n52052) was excium channel-blockers. amined at the occasion of the echocardiographic substudies of the MONICA (Monitoring of Trends and Determinants in Cardiovascular Disease) surveys in Augsburg, Germany, 2.4. G protein b3-subunit polymorphism in 1994 (n5675) and in 1995 (n51675). The population was studied by physical examination, blood testing, and a DNA was extracted from whole blood drawn from all standardised interview including socio-economic backindividuals and the GNB3 genotype was determined ground, history and actual presence of coronary risk factors according to the protocols described previously [2, 5] . (such as arterial hypertension, hypercholesterolemia, diaBriefly, PCR reactions were performed with the primers betes mellitus, cigarette smoking) as well as medication.
59-TGACCCACTTGCCACCCGTGC-39 (sense) and 59-All tests were taken by specially trained personnel in a GCAGCAGCCAGGGCTGGC-39 (antisense) and amstudy centre that provided a relaxed atmosphere. Blood plified with denaturation at 948C for 5 min, followed by 35 pressure was taken according to MONICA guidelines cycles of denaturation at 948C for 1 min, annealing at 648C using the random zero method and standard mercury for 1 min and extension at 728C for 1 min and a final sphygmomanometers [8, 9] . Body weight and height were extension at 728C for 7 min. A second amplification was determined and body mass index was calculated as weight carried out for optimising the results. For this step, the divided by the square of height. Blood was drawn for products were denatured for 5 min at 958C and amplified biochemical analyses from all patients in lying position.
by 35 cycles of denaturation at 958C for 1 min, annealing Serum tubes were centrifuged immediately and sent to the at 638C for 30 s and extension at 728C for 30 s and a final Clinical Chemistry Laboratory of the Central Hospital extension at 728C for 7 min. As primers 59-Augsburg for measurement of glucose, glycosylated CGTGCCCTCAGTTCTTCC-39 (sense) and 59-haemoglobin (HbA1c), total cholesterol, HDL cholesterol, CTGGCCCTTACCCACACG-39 (antisense) were used. LDL cholesterol, and triglycerides. LDL cholesterol levels PCR products were incubated with BseDI restriction were determined using the Friedewald formula when enzyme (0.1 Unit at 608C) (Promega, Germany) and separated on a 2.5% agarose gel. The products were 3. Results visualised by UV translumination. The unrestricted PCR product corresponds to the T allele and has a size of 268 3.1. Anthropometric data bp, whereas the restricted product corresponds to the C allele generating two bands sized 152 bp and 116 bp.
Complete genotyping and phenotyping was available in a total of 2098 individuals from the population-based MONICA survey. From this sample, 46 individuals had 2.5. Statistical evaluation suffered from myocardial infarction and were excluded from the association study with arterial hypertension. In 2
For the comparison of non-parametric values the x test the remainder of the sample (2052 individuals, 1020 males was used, whereas the two-tailed Student's t-test for and 1032 females), the allele frequencies were distributed unpaired and normally distributed samples or ANOVA for according to Hardy-Weinberg equilibrium. Anthropomettesting of parametric values were applied. In addition, ric and biochemical characteristics are shown in Table 1 . multiple regression analysis was performed with the confounding variables detailed for every calculation. An 3.2. Association of the GNB3 polymorphism with error probability of ,0.05 was regarded as statistically arterial hypertension significant. Based on the known distribution of the GNB3 genotypes and an estimated relative risk for arterial
In the population-based MONICA sample, 733 probands hypertension of 1.5 [2] , we calculated for the population-(35.2%) presented with either a history of arterial hybased MONICA sample a power of 0.99 and a least pertension or actual hypertension (blood pressure $160 / significant number of 348 probands to detect a significant 95 mmHg) and / or antihypertensive treatment. The prevalinfluence of the GNB3 gene on mild arterial hypertension ence of arterial hypertension was significantly higher in the (blood pressure $140 / 90 mmHg or antihypertensive TT genotype group as compared to the CC genotype group medication) (a-value of 0.05). The least significant number (41.8 vs. 32.5%, respectively; P50.018; Fig. 1 ). This is the minimal sample size to obtain significant results observation was in part related to an increased utilisation (P,0.05). Using the same parameters for moderate arterial of antihypertensive medication in the TT genotype group hypertension (blood pressure $160 / 95 mmHg or anti-( Table 2 ). These associations were more prominent in hypertensive medication), the power was calculated to be men. In women similar trends could be recognised (Fig.  0 .55 and the least significant number was 1,826. For the 1). Interestingly, when GNB3 genotype distribution was statistical evaluation of data including the power calculaexamined in groups classified as blood pressure of .140 / tion, SPSS software version 9.0 for Windows was used.
90, .160 / 95, .180 / 100 or .190 / 105 mmHg, the TT genotype group was more frequent in men with very high 2.6. Calculation of MI risk conferred by arterial blood pressure (Table 2) . Specifically, in men with the TT hypertension in individuals with the GNB3 TT genotype genotype, the prevalence of a diastolic blood pressure of $105 mmHg was significantly higher (14.4%) than in the Previously, it could be shown that patients with mild CT (7.3%) and the CC genotype groups (4.9%) (P, arterial hypertension, i.e. blood pressure above 140 / 90 0.002). mmHg, carry a relative risk for the development of Linear regression analysis including factors influencing coronary heart disease of 1.67 [11] . According to this blood pressure, such as age, gender, body mass index, and estimate we calculated the theoretical relative risk for MI the GNB3 polymorphism revealed for the GNB3 TT in individuals with the GNB3 TT genotype that can be genotype as compared to the GNB3 CC genotype an attributed to their elevated prevalence of arterial hypertenincrease of the relative risk for arterial hypertension of sion. Details of this calculation are given in the Appendix.
1.51 (95% confidence interval (CI), 1.08-2.11) and for the tensive drug treatment) (data not shown) and after stratifiLikewise, the GNB3 CC, CT, and TT genotypes were cation in subgroups defined by presence or absence of found at similar frequencies in MI patients and in participcoronary risk factors (Table 4) . Given the limitations of ants of the population-based survey with no previous MI, such case-control analysis, we examined whether the lack respectively (Table 3) . Similar results were obtained after of difference in allele frequencies between the MI patients adjustment for potential confounding factors (age, gender, and the survey population might be explained by differbody mass index, systolic blood pressure, and antihyperences in the size or location of infarctions, or the age at the time of infarction, i.e. factors that might affect survival after infarction. However, the age at the time of MI, the Table 4 time that had elapsed between the first MI and presentation
Frequencies of the GNB3 polymorphism in normal population and in patients with myocardial infarction in different subgroups at the study centre, and the localisation or size of the MI, i.e. factors that might affect survival after MI, were a Values are expressed as means. CC and TT genotype represent homozygosity and CT genotype represents heterozygosity for the GNB3 polymorphism; CK, creatine kinase; CK-MB, creatine kinase, heart-specific isoenzyme; systolic and diastolic BP, systolic and diastolic blood pressure, respectively; ‡ † antihypertensive medication, % of subjects on antihypertensive medication. To convert values for cholesterol to mmol / l, multiply by 0.02586. Defined as history of diabetes mellitus, fasting blood glucose .160 mg / dl, HbA1c .6.5% or intake of antidiabetic medication.
103 368 individuals with and without MI need to be blood pressure levels. It, thus, appears that the TT genostudied to document a significant difference between type specifically increases the risk for severe hypertension. groups.
These data may give rise to the hypothesis that the T allele, instead of homogeneously raising the blood pressure by a certain extent, may be without significant effect in a large proportion of the population, but associate with a substantial effect in a small subgroup. This may be of relevance if 4. Discussion the mutation causing arterial hypertension is in linkage disequilibrium but not identical with the T allele. AlterIn the present study we demonstrate a significant natively, specific gene-gene or gene-environment interacassociation of the C825T polymorphism of GNB3 with tions may precipitate arterial hypertension in carriers of the both, arterial hypertension and antihypertensive treatment TT genotype. Further studies have to address these hypothin a large sample of middle European Caucasians. These eses. results confirm the association of the C825T polymorphism Vascular alteration related to the risk of arterial hyof GNB3 with arterial hypertension in a large populationpertension may also affect the risk of MI (as hypertension based sample which was previously reported only on itself increases the risk of MI). Thus, we examined a large smaller and selected populations [2, 3, 5, 7, 12] . In contrast, group of patients suffering from premature MI (i.e. age at other authors observed no significant contribution of this first MI under 60 years). When comparing the allele polymorphism on blood pressure in 479 and 681 cases, frequencies of the GNB3 polymorphism with those of the respectively [3, 6] . An explanation for this discrepancy may population-based sample, no significant difference could be that the effects of the GNB3 polymorphism on systolic be found. This finding indicates the absence of any and / or diastolic blood pressure levels are small and require detectable association of the GNB3 polymorphism with large sample sizes to be detectable.
MI. Similar data were reported previously in a mixed Interestingly, the present large sample of normal populapopulation of MI patients from different regions in Europe tion reveals that the group of individuals subjected to [6] . Since the frequency of the GNB3 T allele varies antihypertensive medication as well as the group with very considerably in both, geographical and ethnic groups [13] , high blood pressure levels were characterised by an excess the previous study on ethnically and geographically disof TT genotype carriers. In another paper [12] , 110 tinct groups may be difficult to interpret. In the present hypertensive individuals with two hypertensive parents and study, we examined cases and controls from exactly the a rather young age of onset were examined and the T allele same geographical region reducing the ascertainment error was also associated with arterial hypertension and higher and confirmed the previously documented negative asAppendix. Calculation of MI risk conferred by sociation.
arterial hypertension in individuals with the GNB3 A limitation of the present study, however, is that only TT genotype survivors of MI were included. It might, thus, be speculated that the apparent lack of association results from poor
Step modest changes in blood pressure in the infrequent GNB3 TT genotype do not translate to a clinically detectable increase in risk of MI. In fact, we calculated the risk of MI In patients with mild arterial hypertension, i.e. blood that arises from the higher prevalence of arterial hypertenpressure above 140 / 90 mmHg, the relative risk for the sion in the TT genotype group to be 1.04. In good development of coronary heart disease was previously agreement with this theoretical estimate, we observed a shown to be 1.67 [11] . To calculate the relative risk of an relative risk of 1.05 that was not significantly different MI in individuals carrying the GNB3 TT genotype, the from 1.0 in the presently studied T individuals with or numbers of all individuals with arterial hypertension without MI. Indeed, based on such risk increment and the (GNB3 TT genotype, n588; GNB3 CT / CC genotypes, low prevalence of the TT genotype, a much larger study n5635) were multiplied by 1.67 (GNB3 TT genotype, with a sample size of greater 100 000 individuals has to be x 5147; GNB3 CT / CC genotypes, x 51060) and the 1 2 examined to test this relationship. numbers of those individuals without arterial hypertension In conclusion, in a large population-based sample we (GNB3 TT genotype, n5123; GNB3 CT / CC genotypes, demonstrated the significant association of the GNB3 825T n51206) were multiplied by 1.0 (no risk increase; GNB3 allele with elevated diastolic blood pressure, predominant-TT genotype, y 5123; GNB3 CT / CC genotypes, y 5 1 2 ly in men without antihypertensive medication, but not on 1206). other coronary risk factors. Furthermore, no association of the GNB3 polymorphism with MI could be found.
Step 2
For determination of the risk ratio for MI (RR ) the MI calculated products of individuals carrying the GNB3 TT Acknowledgements genotype were added (x 1 y 5 270) and were divided by 
